Featured: 2019
About the 2019 Ride

The 2019 Road to Victory event will take one big team of 30 cyclists winding through small Vermont villages at the height of New England’s iconic fall foliage.

The team will pedal across covered bridges and past babbling brooks while challenging themselves over rolling hills. They will bid farewell to the Green Mountain State as their journey takes them over the international border and into Quebec – crossing the border in a peloton of bikes is quite the experience! This team will catch stunning views of Lake Memphremagog and soak in this glacier-carved landscape offering incredible vistas with exhilarating elevation gain!

    2018 Rides
    $420,889 Raised
    About Event

    London to Paris

    R2V Team members took on a 3-day, bike ride from through the English countryside to the villages on France, and finally along the Champs de Elyse to the finish line: The Eiffel Tower.

    Glacier Grandeur

    The 6-Day ride took R2V team on a beautiful, challenging 300 mile journey through Glacier National Park and on to Canada’s Waterton Lakes National Park.

    Red Rocks

    R2V team members were challenged to six days of epic riding through Utah’s Bryce Canyon and Zion National Park.

    Team Members
    2017 Rides
    $746,386 Raised
    About Event

    Cross Country

    Seven cyclists, all with a direct connection to multiple myeloma, rode 3,400 miles from Manhattan Beach, California to Fairfield, Connecticut, to kick off the Road to Victories Program.

    7 Day Ride

    The cross-country riders were escorted on the first seven days of the ride by a group of 11 Road to Victories team members. This grueling 544 miles took riders from LA through the Mojave Desert and then up the mountains to Flagstaff, AZ.

    Team Members
    The mission of the Multiple Myeloma Research Foundation (MMRF) is to find a cure for multiple myeloma by relentlessly pursuing innovation that accelerates the development of next-generation treatments to extend the lives of patients. Founded in 1998 by Kathy Giusti, a multiple myeloma patient, and her twin sister Karen Andrews as a 501(c) (3) nonprofit organization, the MMRF is a world-recognized leader in cancer research. Together with its partners, the MMRF has created the only end-to-end solution in precision medicine and the single largest genomic dataset in all cancers. The MMRF continues to disrupt the industry today, as a pioneer and leader at the helm of new research efforts. Since its inception, the organization has raised over $400 million and directs nearly 90% of the total funds to research and related programs. Learn more and sign up to receive news and resources from the MMRF.

    Learn More

    At Janssen Oncology, we’re shaping the future of cancer treatment. In the process, we’re striving to change expectations of what a cancer diagnosis means. Our purpose is driven by an urgency and commitment to bringing transformational cancer solutions to the people who need them. Passionate about our work, we are driven by the personal connection many of us share with the disease. With our partners, we focus on delivering solutions that make a positive impact on human health. We are part of Janssen Biotech, Inc., and the Janssen Pharmaceutical Companies of Johnson & Johnson.

    About Janssen Oncology

    Click below to learn more about a treatment option for multiple myeloma. If you’re also interested in getting more information from Janssen, sign up for ongoing communications.

    Learn More